Ginkgo Bioworks
DNA
DNA
341 hedge funds and large institutions have $1.51B invested in Ginkgo Bioworks in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 110 increasing their positions, 93 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $2.22B → $1.51B (-$713M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less call options, than puts
Call options by funds: $2.68M | Put options by funds: $4.3M
Holders
341
Holding in Top 10
2
Calls
$2.68M
Puts
$4.3M
Top Buyers
| 1 | +$27.8M | |
| 2 | +$11.5M | |
| 3 | +$5.04M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$3.48M |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$3.34M |
Top Sellers
| 1 | -$56.7M | |
| 2 | -$10.4M | |
| 3 | -$8.03M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$3.82M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$2.94M |